Evaluation of Safety and Immunogenicity of rVSVΔG-SEBOV-GP Vaccine in Adults With Good General Health

NCT05724472 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

NETWORK

Sponsor class

Conditions

Ebola Sudan Virus Disease

Interventions

DRUG: rVSV∆G-SEBOV-GP Vaccine or Placebo

Sponsor

International AIDS Vaccine Initiative

Collaborators

[object Object]